David Rosenkranz

1.8k citations
31 papers · 1.1k indexed · h-index 18
Topics
Chromosomal and Genetic Variations (13 papers)CRISPR and Genetic Engineering (11 papers)RNA modifications and cancer (7 papers)

In The Last Decade

David Rosenkranz

31 papers receiving 1.1k citations

Peers

David Rosenkranz
Comparison fields: 5 of 94
  • Molecular Biology 886
  • Plant Science 431
  • Cancer Research 290
  • Genetics 172
  • Ecology 81
Replace Yong E. Zhang with:
Yong E. Zhang China
John H. Malone United States
Manuela Weier Switzerland
Camille Berthelot France
Dubravka Pezić United States
Xinyang Bing United States
Jesús Page Spain
Irene Tiemann‐Boege Austria
Ben‐Yang Liao Taiwan
Maria Pia Bozzetti Italy
David Rosenkranz relative to Yong E. Zhang China Yong E. Zhang's profile →
Citations per field
00.5×1.5×
Yong E. Zhang · 1×
Citations per year

Countries citing papers authored by David Rosenkranz

Since Specialization
Citations

This map shows the geographic impact of David Rosenkranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rosenkranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rosenkranz more than expected).

Fields of papers citing papers by David Rosenkranz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rosenkranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rosenkranz. The network helps show where David Rosenkranz may publish in the future.

Co-authorship network of co-authors of David Rosenkranz

This figure shows the co-authorship network connecting the top 25 collaborators of David Rosenkranz. A scholar is included among the top collaborators of David Rosenkranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Rosenkranz. David Rosenkranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 12
3 37
4 8
5 1
6 117
7 9
8 56
9 27
10 30
11 80
12 19
13 26
14 16
15 41
16 30
17 65
18 36
19 139
20 5

About David Rosenkranz

David Rosenkranz is a scholar working on Aging, Cancer Research and Plant Science, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chromosomal and Genetic Variations (13 papers), CRISPR and Genetic Engineering (11 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (290 citations), Molecular Biology (886 citations) and Aging (21 citations). David Rosenkranz has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Hans Zischler, Daniel Gebert, René F. Ketting, Charlotte Hewel, Elke F. Roovers, Tina Han, Falk Butter, Holger Herlyn, Bernard A. J. Roelen and Wenfei Sun. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026